Risk Factors for Development of Coronary Artery Disease in Women with Systemic Lupus Erythematosus

被引:61
|
作者
Goldberg, Robert J. [1 ]
Urowitz, Murray B. [1 ]
Ibanez, Dominique [1 ]
Nikpour, Mandana [1 ]
Gladman, Dafna D. [1 ]
机构
[1] Univ Toronto, Div Rheumatol, Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis,Lupus Clin, Toronto, ON M5T 2S8, Canada
关键词
SYSTEMIC LUPUS ERYTHEMATOSUS; CORONARY ARTERY DISEASE; WOMEN; RISK FACTORS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; HEART-DISEASE; ATHEROSCLEROSIS; COHORT; HYPERTRIGLYCERIDEMIA; PREVALENCE; NECROSIS; FEATURES; RATES;
D O I
10.3899/jrheum.090011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To ascertain coronary artery disease (CAD) outcomes and predictive factors in a prospective Study of patients with systemic lupus erythematosus (SLE) and matched healthy controls. Methods. SLE patients and non-SLE age-matched controls without a history of CAD were recruited into a prospective Study between 1997 and 1999. CAD events were assessed at clinic visit for SLE patients and through telephone interview and chart review for controls. All events were verified with patient medical records. Results. Followup information wits available on 237 controls and 241 SLE patients. The mean followup time was 7.2 years. Univariate analyses identified age and postmenopausal status as predictors of CAD in both the groups. Sedentary lifestyle, hypertension, the presence of metabolic syndrome, and the number of Framingham risk factors were predictive in the control group only. The 10-year risk of CAD score was predictive in both goups but was not as marked in the SLE group as in the controls. None of the lipid subfractions were predictive for CAD in the SLE group, whereas in the controls, a high triglyceride level >= 2.8 was predictive. Time-to-event multivariate analysis for CAD in all subjects revealed SLE itself, older age, and triglycerides >= 2.8 to be highly predictive for CAD. Conclusion. In a prospective study of patients with SLE and matched controls followed over a median of 8 years, patients with SLE developed significantly more CAD events than controls. Accounting for demographic variability, CAD risk factors, and lipid factors, SLE is an independent risk factor for the development of CAD. (First Release Oct 15 2009: J Rheumatol 200936:2454-61; doi: 10.3899/jrheum.090011)
引用
收藏
页码:2454 / 2461
页数:8
相关论文
共 50 条
  • [41] Impaired metabolism predicts coronary artery calcification in women with systemic lupus erythematosus
    Urbain, Fanny
    Ponnaiah, Maharajah
    Ichou, Farid
    Lhomme, Marie
    Materne, Clement
    Galier, Sophie
    Haroche, Julien
    Frisdal, Eric
    Mathian, Alexis
    Durand, Herve
    Pha, Micheline
    Hie, Miguel
    Kontush, Anatol
    Cluzel, Philippe
    Lesnik, Philippe
    Amoura, Zahir
    Guerin, Maryse
    Aubart, Fleur Cohen
    Le Goff, Wilfried
    EBIOMEDICINE, 2023, 96
  • [42] Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease
    Hochman, J.
    Urowitz, M. B.
    Ibanez, D.
    Gladman, D. D.
    LUPUS, 2009, 18 (04) : 313 - 317
  • [43] Lack of subclinical myocardial ischaemia in Mexican patients with systemic lupus erythematosus without traditional risk factors for coronary artery disease
    Garcia-Carrasco, M.
    Escarcega, R. O.
    Perez-Terron, J.
    Ramirez, A.
    Munoz-Guarneros, M.
    Beltran, A.
    Perez-Cuevas, B.
    Lopez-Colombo, A.
    Cervera, R.
    LUPUS, 2007, 16 (04) : 298 - 301
  • [44] Frequency of established cardiovascular disease and its risk factors in Chinese patients with systemic lupus erythematosus
    Wang, Xiao-Yang
    Tang, Xue-Qing
    Huang, Ya-Juan
    Chen, Wei-Ying
    Yu, Xue-Qing
    CLINICAL RHEUMATOLOGY, 2012, 31 (04) : 669 - 675
  • [45] Nephritis and the risk of acute myocardial infarction in patients with systemic lupus erythematosus
    Wells, D. K.
    Ward, M. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : 223 - 229
  • [46] Prevalence of and risk factors for the metabolic syndrome in women with systemic lupus erythematosus
    Bultink, I. E. M.
    Turkstra, F.
    Diamant, M.
    Dijkmans, B. A. C.
    Voskuyl, A. E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (01) : 32 - 38
  • [47] Cardiovascular risk assessment and treatment in systemic lupus erythematosus
    Elliott, Jennifer R.
    Manzi, Susan
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2009, 23 (04): : 481 - 494
  • [48] Pregnancy outcomes and risk factors in pregnant women with systemic lupus erythematosus
    Zhang, Li Li
    Shu, Hua
    Zhang, Shuai
    Wang, Tian Tian
    Zhang, Lan Lan
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2020, 47 (02) : 189 - 193
  • [49] Spontaneous coronary artery dissection in systemic lupus erythematosus: case-based review
    Alvarez-Lario, Bonifacio
    Alvarez-Roy, Laura
    Mayordomo-Gomez, Sandra
    Marcos Garcia-Garcia, Juan
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (10) : 1821 - 1827
  • [50] Systemic lupus erythematosus and cardiovascular disease
    Frostegard, Johan
    JOURNAL OF INTERNAL MEDICINE, 2023, 293 (01) : 48 - 62